Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.275
-0.005 (-0.39%)
Mar 31, 2025, 1:39 PM EDT - Market open

Climb Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
15.399.8918.9212.352.43
Upgrade
Research & Development
11.6111.5826.2123.329.34
Upgrade
Operating Expenses
2721.4745.1435.6711.77
Upgrade
Operating Income
-27-21.47-45.14-35.67-11.77
Upgrade
Interest & Investment Income
7.382.291.20.45-
Upgrade
Currency Exchange Gain (Loss)
-0.010.54-1.48-0.170.26
Upgrade
Other Non Operating Income (Expenses)
----11.72-
Upgrade
EBT Excluding Unusual Items
-19.64-18.64-45.42-47.11-11.51
Upgrade
Merger & Restructuring Charges
-3.36-18.81---
Upgrade
Gain (Loss) on Sale of Investments
0.762.330.18-0.37-
Upgrade
Pretax Income
-73.9-35.12-45.24-47.48-20.67
Upgrade
Net Income
-73.9-35.12-45.24-47.48-20.67
Upgrade
Preferred Dividends & Other Adjustments
---4.552.29
Upgrade
Net Income to Common
-73.9-35.12-45.24-52.03-22.95
Upgrade
Shares Outstanding (Basic)
482726122
Upgrade
Shares Outstanding (Diluted)
482726122
Upgrade
Shares Change (YoY)
78.47%2.57%114.60%460.40%31.72%
Upgrade
EPS (Basic)
-1.53-1.30-1.72-4.24-10.49
Upgrade
EPS (Diluted)
-1.53-1.30-1.72-4.24-10.49
Upgrade
EBIT
-27-21.47-45.14-35.67-11.77
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q